Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Retatrutide is a novel triple-agonist peptide engineered to activate three metabolic hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon receptors Unlike single or dual incretin therapies, retatrutide is designed to produce a broader metabolic response by influencing appetite regulation, energy expenditure, and glucose metabolism all at once
Eating disorder risk For individuals with a history of disordered eating, GLP-1-induced appetite suppression can unintentionally reinforce restriction or trigger old patterns
Does the savings card work if my insurance doesnt cover Wegovy
Who funded the existing evidence, and do they sell the product
Provide ways to lower medication costs Many patients have to take GLP-1s long-term, especially if they want sustained effects
US$ 22.66
US$ 21.96
US$ 24.60
US$ 20.19
US$ 22.27
US$ 23.38
US$ 27.98
